ATEC - Piper sees GLP-1s increasing demand for knee/hip surgeries near-term
2023-12-03 17:58:12 ET
More on Novo Nordisk, Stryker, etc.
- Why Stryker Is An Awesome Healthcare Compounder
- Stryker Corporation (SYK) 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation
- Novo Nordisk reportedly paid over $25M to doctors to promote obesity drugs
- EU regulators seeking more info on GLP-1s and suicidal thoughts: report
For further details see:
Piper sees GLP-1s increasing demand for knee/hip surgeries near-term